BrightPath Bio
- Biotech or pharma, therapeutic R&D
BrightPath Bio (Tokyo Stock Exchange: 4594) is a clinical-stage biopharmaceutical company focused on oncology.
June 16-19, 2025
Boston Convention & Exhibition Center
BrightPath Bio (Tokyo Stock Exchange: 4594) is a clinical-stage biopharmaceutical company focused on oncology.